ImmunityBio, Inc. - Common Stock — 재무제표 (NASDAQ:IBRX) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 151.86 M468.91 M362.36 M504.45 M382.93 M501.9 M 총 부채 34.47 M712.82 M812.18 M1.09 B871.06 M1 B 자본금 총액 117.39 M-243.91 M-449.82 M-585.94 M-488.13 M-499.57 M 총 부채 및 주주자본 151.86 M468.91 M362.36 M504.45 M382.93 M501.9 M 총부채 ———837.02 M284.4 M326.37 M 순부채 ———570.55 M134.59 M83.55 M

뉴스

IBRX and the BCG Shortage: Deals That Could Expand Demand

IBRX Stock Outlook After Q1 Results and a New FDA Review

ImmunityBio: Anktiva Explained and What Comes Next

Undercovered Stocks: Cerebras Systems, Infleqtion, Duos Technologies And More

FDA Accepts IBRX's Filing Seeking Expanded Use of Bladder Cancer Therapy

ImmunityBio Secures Five U.S. Patents for Anktiva in Bladder Cancer

ImmunityBio: Looking Beyond Bladder Cancer To A Multibillion-Dollar Solid Tumor TAM (IBRX)

ImmunityBio (IBRX) Reports Q1 Loss, Tops Revenue Estimates

Why ImmunityBio Stock Is Surging On Wednesday? - ImmunityBio (NASDAQ:IBRX)

ImmunityBio to Report Q1 Earnings: What's in the Cards?

IBRX Global Rollout: EU, MENA, and Asia Shape 2026-27 Catalysts

Is IBRX Priced for Perfection at Nearly 28x Forward Sales?